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Prenatal screening
a guide for expectant parents
information about screening tests for chromosomal and structural abnormalities
This information booklet is 
intended for all expectant parents. 
It is hoped that the parents 
read the booklet together. 
Participation in prenatal  
screening is voluntary.
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Why are there prenatal screening 
tests for abnormalities? 
n A number of different tests are offered to expectant 
mothers in prenatal and maternity hospital clinics to find 
out whether the pregnancy is developing normally and to 
get information about possible risks. 
Every expectant parent hopes for a normal develop-
ment of the foetus and a healthy child.  This wish is fulfilled 
in most cases but not always. About three in a hundred 
newborn children are found to have a structural or chro-
mosomal abnormality.  One in a hundred children is found 
to have a severe abnormality. Some abnormalities can be 
detected by means of tests done during pregnancy. 
However, there are many foetal diseases and structural 
abnormalities that cannot be detected during pregnancy. 
The screening methods described in this booklet have been 
selected and scheduled so as to make sure that they are as 
accurate and reliable as possible. 
Many expectant parents wish to be informed about 
possible foetal abnormalities as this may help monitor 
the pregnancy and prepare for delivery. Detecting a foetal 
disease before delivery may also help in planning the care 
of the newborn child. If a severe foetal disease or defect or 
an increased risk of a severe disease or defect is found, the 
expectant parents will have an opportunity to decide on 
possible termination of pregnancy.    
Before making the decision to participate in the screen-
ing programme, the expectant parents should also consider 
the consequences that the decision might have. Fortunately, 
test results are mostly normal. However, it is possible that 
the results indicate an increased risk of a defect or disease. 
After the test results are available, you will have only a little 
time for consideration in order to decide on further tests 
and whether to continue or terminate the pregnancy. 
All screening tests 
are voluntary. 
It is the family 
and ultimately the 
pregnant woman 
herself who decide 
whether to partici-
pate in the tests. 
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What do the screening tests look 
for and what are they able to find? 
n The risk of abnormality increases with the mother’s 
age. Some chromosomal abnormalities can be screened 
by tests done during pregnancy. The most common chro-
mosomal abnormality is Down syndrome (trisomy 21).  A 
screening test may also reveal an increased risk of other 
chromosomal abnormalities. Various structural abnormali-
ties, in turn, can be detected by ultrasound examinations 
even if the chromosomes were found to be normal.
Early pregnancy general  
ultrasound examination
n Early Pregnancy General Ultrasound at 10–13 weeks of 
pregnancy is available for all pregnant women. The main 
purpose of the examination is to confirm that the foetus 
is alive and to accurately determine the duration of preg-
nancy, as well as to find out how many foetuses there are. 
The examination is painless and harmless to the foetus. 
Although the purpose is not to look for foetal abnormali-
ties, some significant and severe structural abnormalities 
may already be revealed in the examination. If there is a 
suspicion of abnormality, the expectant parents will be 
informed. However, many structural abnormalities cannot 
yet be seen at this stage of pregnancy. 
The maternity clinic 
sees to it that the 
examinations are 
carried out at the 
right time. 
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Screening for foetal abnormalities
n  A nuchal translucency (NT) scan can be combined with 
the early pregnancy general ultrasound. It measures the 
amount of fluid behind the neck of the foetus in order to 
screen for chromosomal abnormalities. Please tell your 
doctor or nurse before the general ultrasound if you want 
to participate in the NT screening for chromosomal abnor-
malities.  
early pregnancy combined screening 
Early Pregnancy Combined Screening is the primary method 
of screening chromosomal abnormalities:   A blood test is 
taken from the pregnant woman at 9–11 weeks of preg-
nancy. The general ultrasound is scheduled at 11–13 weeks 
of pregnancy and the NT scan is carried out at the same 
time. When the results of the blood test are combined 
with the NT scan results, it is possible to identify a foetus 
at increased risk of chromosomal abnormality.  
You will be informed about the results of the chro-
mosome screening test by your own prenatal clinic or a 
regional prenatal screening unit.  
If the combined screening test indicates an increased 
risk of chromosomal abnormality, the expectant parents 
are offered an opportunity to have a prenatal chromo-
some test done using a sample of the placenta or amniotic 
fluid. These further tests establish whether the foetus has 
normal chromosomes. About one in one to two hundred 
tests where a sample is taken of the mother’s placenta or 
amniotic fluid lead to a miscarriage.  
If the combined screening test cannot be performed, a 
second trimester blood screening test can be done at 15–16 
weeks of pregnancy. 
No screening methods where a sample is taken of 
the mother’s blood can be used in twin or other multiple 
Falling into the risk 
group at the first 
screening stage does 
not yet mean that 
the foetus would 
have a disease or 
defect.
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pregnancies. However, the risk of chromosomal abnor-
mality can be assessed even in this case by measuring the 
amount of fluid behind the back of the foetus using the 
NT scan. 
The older the mother is, the higher the risk of chromo-
somal abnormalities.  If the mother is aged 40 or over, she 
may be offered a prenatal chromosome test done directly 
from a placenta or amniotic fluid sample without preced-
ing screening.
structural ultrasound examination
Structural Ultrasound at 18–21 weeks of pregnancy is avail-
able for all pregnant women. It is a systematic examination 
of foetal organs. The examination is painless and harmless 
to the foetus. 
The results are reported to the mother at the same 
time as the ultrasound examination is done. An abnormal 
result is always confirmed by a new examination, which is 
often performed in another hospital. However, the neces-
sary further testing is planned as required according to 
each detected abnormality. 
ultrasound examination after 24+0 weeks 
of pregnancy 
From 24+0 weeks of pregnancy onwards, a termination of 
pregnancy on the grounds of a foetal abnormality is no 
longer possible.  Nevertheless, the detection of structural 
abnormalities may help plan the care of the child to be 
born. This ultrasound examination can be performed in 
place of the examination to be performed at 18–21 weeks 
of pregnancy.
The screening programmes offered to families comply with the Government Decrees on 
Screening Programmes No. 1339/2006 and 280/2009. For further information in Finnish 
or Swedish please visit:  www.stm.fi
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Simplified representation of the options available in prenatal screening
Does not  
participate in
chromosome 
screening
Weeks  
10+0–13+6
General  
Ultrasound 
Weeks 9+0–11+6
blood screening 
Weeks 11+0–13+6 
NT  &
General  
Ultrasound OR
Weeks 15+0–16+6
blood screening 
& General Ultra-
sound
Participates in 
chromosome 
screening
P 
P 
Counselling,
further testing,
planning care or 
considering ter-
mination
Participates in 
neither chromo-
some screening
nor ultrasound 
examinations
First prenatal cli-
nic visit:
counselling
THL 2009
Prenatal screening – A guide for expectant parents
7
Simplified representation of the options available in prenatal screening
 P  =abnormal result; NT = nuchal translucency; 
Weeks =weeks of pregnancy. The duration of pregnancy is 
expressed as weeks + days.
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